Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy.

Okubo R, Hasegawa T, Fukuyama K, Shiroyama T, Okada M

Open source

DOI
10.3389/fpsyt.2021.623684
Published
2021
Container
Frontiers in psychiatry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fpsyt.2021.623684,
  title = {Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy.},
  author = {Okubo R and Hasegawa T and Fukuyama K and Shiroyama T and Okada M},
  year = {2021},
  journal = {Frontiers in psychiatry},
  doi = {10.3389/fpsyt.2021.623684},
  url = {https://doi.org/10.3389/fpsyt.2021.623684}
}

RIS

TY  - JOUR
TI  - Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy.
AU  - Okubo R
AU  - Hasegawa T
AU  - Fukuyama K
AU  - Shiroyama T
AU  - Okada M
PY  - 2021
JO  - Frontiers in psychiatry
DO  - 10.3389/fpsyt.2021.623684
UR  - https://doi.org/10.3389/fpsyt.2021.623684
ER  - 

APA

R, O., T, H., K, F., T, S., & M, O. (2021). Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy.. Frontiers in psychiatry. https://doi.org/10.3389/fpsyt.2021.623684

Source records